Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities:      
Consolidated net income (loss) $ 748.5 $ 526.2 $ (378.1)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 489.6 399.3 337.3
Stock-based compensation expense 54.9 54.7 49.7
Deferred income taxes 9.3 66.5 (82.7)
Loss (gain) on fair market value adjustment of equity investments 63.6 (149.5) 0.0
Gain on sale of asset (4.6) 0.0 0.0
Gain on divestiture (0.2) 0.0 0.0
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (66.2) (93.7) (61.3)
Other assets, current and long-term 16.4 35.8 (78.8)
Current and long-term liabilities, excluding debt 23.5 106.9 527.7
Cash provided by operating activities 1,334.8 946.2 313.8
Investing activities:      
Capital expenditures (469.0) (421.3) (399.6)
Acquisitions, net of cash acquired (2,935.6) (61.4) (272.9)
Cash received from sale of asset 4.9 0.0 0.0
Cash received from divestitures 1.5 0.0 0.0
Investment in unconsolidated affiliates, net 0.0 (10.0) (25.0)
Cash used in investing activities (3,398.2) (492.7) (697.5)
Financing activities:      
Net short-term borrowings (repayments) 323.4    
Net short-term borrowings (repayments)   (0.7) (1.8)
Payments on long-term debt (1,100.2) (125.0) (250.0)
Proceeds from issuance of long-term debt 1,697.1 1,123.3 998.3
Treasury stock purchases (69.9) 0.0 0.0
Dividends paid to Equifax shareholders (190.0) (189.5) (188.7)
Dividends paid to noncontrolling interests (6.5) (4.6) (6.6)
Proceeds from exercise of stock options and employee stock purchase plan 46.8 41.7 22.3
Payment of taxes related to settlement of equity awards (57.3) (15.9) (10.5)
Purchase of redeemable noncontrolling interests (11.2) (9.0) 0.0
Debt issuance costs (14.5) (9.8) (5.1)
Other 0.0 0.3 0.0
Cash provided by financing activities 617.7 810.8 557.9
Effect of foreign currency exchange rates on cash and cash equivalents (14.2) 19.0 3.5
(Decrease) increase in cash and cash equivalents (1,459.9) 1,283.3 177.7
Cash and cash equivalents, beginning of period 1,684.6 401.3 223.6
Cash and cash equivalents, end of period $ 224.7 $ 1,684.6 $ 401.3